Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose)-Reference-Cited by-同舟云学术

Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose)

Published:2002-06 Issue:11 Volume:89 Page:1308-1310
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Alsheikh-Ali Alawi A.,Abourjaily Heather M.,Karas Richard H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference4 articles.

1. Recent developments and emerging therapies for type 2 diabetes mellitus;Evans;Drugs,1999

2. Thiazolidinediones and liver toxicity;Scheen;Diabetes Metabol,2001

3. Hepatocellular injury in a patient recieving rosiglitazone;Al-Salman;Ann Inter Med,2000

4. Hepatic failure in a patient taking rosiglitazone;Forman;Ann Inter Med,2000

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Water/pH dual responsive in situ calcium supplement collaborates simvastatin for osteoblast promotion mediated osteoporosis therapy via oral medication;Journal of Controlled Release;2021-01

2. Association between Concomitant Use of Acyclovir or Valacyclovir with NSAIDs and an Increased Risk of Acute Kidney Injury: Data Mining of FDA Adverse Event Reporting System;Biological and Pharmaceutical Bulletin;2018

3. Pleiotropic effects of metformin to rescue statin-induced muscle injury and insulin resistance: A proposed mechanism and potential clinical implications;Medical Hypotheses;2017-09

4. A tutorial on the use of instrumental variables in pharmacoepidemiology;Pharmacoepidemiology and Drug Safety;2017-02-27

5. Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing;Journal of Hepatology;2012-02